Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.
about
IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infectionVaccines for Pseudomonas aeruginosa: a long and winding roadA novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models.Expression and glycoengineering of functionally active heteromultimeric IgM in plants.IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigensThe anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem.A Microarray-Matrix-assisted Laser Desorption/Ionization-Mass Spectrometry Approach for Site-specific Protein N-glycosylation Analysis, as Demonstrated for Human Serum Immunoglobulin M (IgM).Pangenome-wide and molecular evolution analyses of the Pseudomonas aeruginosa species.In vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa.Recent developments for Pseudomonas vaccines.Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update.Precision medicine for the treatment of severe pneumonia in intensive care.Investigational drugs in phase I and phase II clincial trials for the treatment of hospital-acquired pneumonia.Targeting the gram-negative bacteria peptidoglycan synthase MraY as a new approach for monoclonal antibody anti-bacterial activity.Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France.Introduction of germline residues improves the stability of anti-HIV mAb 2G12-IgMPharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.Therapeutic antibodies and infectious diseases, Tours, France, November 20-22, 2012.Evaluating the bottlenecks of recombinant IgM production in mammalian cells.Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection.Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.
P2860
Q24631904-40C756A8-1FAE-4165-B125-D3434EA6A94FQ26852817-ACDF13C5-BD03-4D5A-8E75-A64087540397Q30408273-68A42253-8AE7-4BC1-A58E-8A78571835B5Q30412932-8EBC8053-9BFE-45A0-A63B-CBF33ABE6ADBQ34636867-51E3DE3F-075D-42DC-BF45-C08D03839E27Q34984415-AEFBAA2E-546C-4BED-BBF0-782C9D7F609CQ35584921-58644CF0-B65F-46C6-9698-0695BC165169Q35891241-AAA0A9A2-3CB5-41A4-964C-EEA2D2BF1012Q36613653-A39EEA28-C6D3-4601-976D-80CDDAF71AB6Q37937369-D845BB27-4D90-4327-96D2-284A11105545Q38210319-007ABCCF-3E66-4660-8CD9-C9E27396BD15Q38704065-88278396-A868-46D8-BCD7-6F2F6000A166Q38783043-4315C023-EC89-401F-93B4-C7E8CA46CDDFQ40176262-23859ADB-46B2-42F8-87F6-3C7CAEDB75ADQ40644061-28855432-0D90-483E-94EB-189930BCB13CQ41273804-31BAD0C0-92A1-47B1-BCA0-51B9569089F1Q42694092-37B5D313-EAA2-4ABC-98E5-DD1427C2B500Q42846265-339A00EB-5878-48C3-9DB1-6284927FDFB5Q43147941-C5F7943C-48C8-4429-85D7-06477FAB7CE7Q44121558-C02AED99-C2C9-4EDD-B0EC-D696A0B2900FQ51732617-4EA96D8B-5DC7-4F41-BEEB-3032A89D0080
P2860
Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Preclinical in vitro and in vi ...... aeruginosa serotype IATS-O11.
@ast
Preclinical in vitro and in vi ...... aeruginosa serotype IATS-O11.
@en
type
label
Preclinical in vitro and in vi ...... aeruginosa serotype IATS-O11.
@ast
Preclinical in vitro and in vi ...... aeruginosa serotype IATS-O11.
@en
prefLabel
Preclinical in vitro and in vi ...... aeruginosa serotype IATS-O11.
@ast
Preclinical in vitro and in vi ...... aeruginosa serotype IATS-O11.
@en
P2093
P2860
P356
P1476
Preclinical in vitro and in vi ...... s aeruginosa serotype IATS-O11
@en
P2093
Adrian W Zuercher
Alois B Lang
Hedvika Lazar
Martin A Imboden
Michael P Horn
Michael P Rudolf
Stefanie C Fas
P2860
P304
P356
10.1128/AAC.01142-09
P407
P50
P577
2010-03-22T00:00:00Z